We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more Skip to Main Content
Skip Nav Destination

Latest articles

A Cold Case
Amanda K Hempel et al.
A previously healthy 33-year-old man presented to the emergency department with a 3-month history of 2 painless, enlarging masses on his back. He did not report fever, chills, weight loss, or night sweats. There were no associated respiratory or neurologic symptoms. He was born in Trinidad and Tobago but had moved to ...
In the Literature
Andrade CM, Fleckenstein H, Thomson-Luque R, et al. Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season. Nat Med 2020;26(12):1929–40. doi: 10.1038/s41591-020-1084-0. Epub ahead of print: 26 October 2020. PMID: 33106664. In Mali, as in other areas of ...
Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study
Megan M Sheehan, BS et al.
Background Protection afforded from prior disease among patients with coronavirus disease 2019 (COVID-19) infection is unknown. If infection provides substantial long-lasting immunity, it may be appropriate to reconsider vaccination distribution plans. Methods This retrospective cohort study of one multi-hospital health ...
A Phase 3, Randomized, Double-Blind Study Comparing Tedizolid Phosphate and Linezolid for Treatment of Ventilated Gram-Positive Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
Richard G Wunderink et al.
Tedizolid was noninferior to linezolid for all-cause mortality in the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia. Noninferiority of tedizolid to linezolid for investigator-assessed clinical response at test of cure was not demonstrated. Both drugs were well tolerated.
Plasma kynurenine-to-tryptophan ratio, a highly sensitive blood-based diagnostic tool for Tuberculosis in HIV-infected pregnant women
Clement Adu-Gyamfi et al.
Background For pregnant women living with human immunodeficiency virus (HIV), concurrent active Tuberculosis (TB) disease increases the risk of maternal mortality and poor pregnancy outcomes. Plasma indoleamine 2,3-dioxygenase (IDO) activity, measured by kynurenine-to-tryptophan (K/T) ratio has been proposed as a ...

Editor's Choice

John Bartlett, In Memoriam
Sherwood L Gorbach
In the many tributes that have poured in since the passing of John Bartlett on January 19, 2021, the phrase that reverberates is “the passing of a legend.” I had known John for 50 years since we met in 1970 and worked closely with him for 8 years, initially at Sepulveda VA Hospital in California and then at Tufts Medical ...
Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA’s Diagnostics Committee
Kimberly E Hanson et al.
Molecular assays have revolutionized the diagnosis of acute respiratory tract infections. However, many unanswered questions about the optimal use and cost-effectiveness of these tests remain. Additional prospective diagnostic studies are needed to measure impact on medical decision making and clinical outcomes.
We Need to Address the Health of Children at the Border
Betsy C Herold et al.
Military guidance emphasizes the importance of immunization in the prevention of respiratory disease outbreaks [ 15 ]. It is therefore particularly egregious that our government has chosen to withhold influenza vaccine from individuals in border detention facilities. On 21 August 2019, the Pediatric Infectious Diseases ...
A “Natural Death”: The Political Battlefield of Infections and Migrant Children’s Bodies
Mark A Travassos
Recent deaths of migrant children from overwhelming infections in US detainment centers have brought to light outbreaks in these facilities, delays in medical care, and inadequate medical expertise. Advocacy by clinicians and professional societies is critical to resolving this crisis.
Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute
Michael J Satlin et al.
Daptomycin is one of the few treatment options for infections caused by enterococci that are resistant to ampicillin and vancomycin, such as vancomycin-resistant Enterococcus faecium . The emergence and clinical significance of daptomycin-resistant enterococci and evolving microbiologic, pharmacokinetic-pharmacodynamic, ...

Society Members

For your free access to this journal, log in via the IDSA members area.

Register to receive email alerts, and keep up to date with the latest Clinical Infectious Diseases articles as soon as they are published online. And, with the IDSA Journals app, it's easy to stay connected, giving you the freedom to read the journal both online and offline, on your iPad, iPhone, or iPod Touch.
Sign up for alerts

Trending Articles

Discover the top Clinical Infectious Diseases articles, sorted by Altmetric Score, that have been mentioned online in the past month.

Explore the articles

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close